White Matter Plasticity in Schizophrenia
1 other identifier
interventional
36
1 country
2
Brief Summary
Schizophrenia spectrum disorders are associated with impairment in the microstructure of white matter, the key brain tissue responsible for fast communication between different brain regions necessary for any complex task. This white matter impairment is linked to problems with cognition in schizophrenia, especially slower processing speed. This project aims to study the potential for correcting white matter deficits in schizophrenia by examining mechanisms underlying white matter structure changes in response to training on playing a mock musical instrument.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedStudy Start
First participant enrolled
January 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
February 20, 2026
February 1, 2026
2 years
October 11, 2024
February 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
White matter microstructure
fractional anisotropy of white matter tracts as assessed with diffusion tensor imaging
3 weeks
Secondary Outcomes (1)
Brain level of N-acetylaspartate
3 weeks
Study Arms (2)
Active training
ACTIVE COMPARATORTraining sessions involving playing the video game 'Guitar Hero'
Observation training
PLACEBO COMPARATORInterventions
The video game \'Guitar Hero\' will be used as the platform for training for participants to acquire a new \'skill\'
Eligibility Criteria
You may qualify if:
- Diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or psychosis NOS
- age 15-45
- able to provide informed consent
You may not qualify if:
- contraindications to MRI (metal implants, claustrophobia)
- medical condition that limits use of hands (ie, arthritis)
- Active or recent (within 6 months) substance use disorder other than nicotine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Maryland Psychiatric Research Center
Catonsville, Maryland, 21228, United States
University of Maryland Baltimore - Maryland Psychiatric Research Center
Catonsville, Maryland, 21228, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2024
First Posted
October 15, 2024
Study Start
January 2, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
February 20, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share